The U.S. Food and Drug Administration has approved over-the-counter sales of the overdose antidote naloxone, marking the first time an opioid treatment drug will be available without a prescription.
Health
Senators press Moderna CEO on COVID-19 vaccine price hike
Sen. Bernie Sanders, I-Vt., notes that the drugmaker has made over $20 billion in profits over the past two years, and the U.S. government contributed billions toward the shots’ development.
A deadly fungal infection is spreading in hospitals. Here’s what to know
Candida auris is a drug-resistant fungus that ‘presents a serious global health threat,’ according to the CDC.
With overdoses climbing, states look at harsher fentanyl penalties
Imposing longer prison sentences for possessing smaller amounts of drugs represents a shift in states that in recent years have rolled back drug possession penalties.
U.S. pregnancy deaths dropped in 2022, after COVID spike
Officials say the 2022 maternal death rate is on track to get close to pre-pandemic levels. But that’s not great: The rate before COVID-19 was the highest it had been in decades.
What will happen if medication abortion challenge succeeds?
In the latest effort to limit abortion access, opponents of the procedure are seeking to ban 1 of the 2 drugs used in combination in medication abortions.
Chinese SARS whistleblower Jiang Yanyong dies at 91
The military doctor revealed the full extent of the 2003 SARS outbreak and was later placed under house arrest for his political outspokenness.
In nursing homes, impoverished residents live final days on pennies
A half-century-old bit of American bureaucracy is leaving hundreds of thousands of nursing home residents in an unthinkable bind: Living on as little as $30 a month.
Long-used abortion pill in U.S. under threat in Texas lawsuit
A federal judge is being asked to revoke or suspend the FDA’s drug’s approval of the drug 23 years ago, an unprecedented challenge to the federal agency’s role.
3 years later, the pandemic cocoon is giving way to social butterflies
Long after Maine’s first case of coronavirus, communal activities and gatherings are reaching pre-pandemic levels again, though troubling remnants of isolation persist.